Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Zsófia Majláth"'
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 6 (2013)
Dementia is a common neuropsychological disorder with an increasing incidence. The most prevalent type of dementia is Alzheimer’s disease. The underlying pathophysiological features of the cognitive decline are neurodegenerative processes, a cerebr
Externí odkaz:
https://doaj.org/article/349434e24f7b4adb8c602dcb990c8923
Autor:
Adrienn Holczer, Lukács Melinda, János Tajti, László Vécsei, Anna Petrovics-Balog, Anita Must, Zsófia Majláth
Publikováno v:
Ideggyógyászati szemle. 72:397-404
Background and purpose Migraine is one of the most disabling primary headache conditions. We aimed to detect hidden symptoms of anxiety and depression and to survey stress-coping mechanisms and related quality of life in a large migraine population w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::498262ee57fd223fcddfed4fec6f1747
https://doi.org/10.18071/isz.72.0397
https://doi.org/10.18071/isz.72.0397
Publikováno v:
Current Drug Targets. 19:805-814
Multiple sclerosis is a common chronic, disabling autoimmune neurological disease affecting mainly young adults. In its pathomechanism, neurodegenerative and acute inflammatory characteristics are both involved. Disease-modifying therapies aim to red
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8580d40c6b280f8b4455a78ba6fc0bb
https://doi.org/10.2174/1389450117666161223125417
https://doi.org/10.2174/1389450117666161223125417
Publikováno v:
CNS & Neurological Disorders - Drug Targets. 16:234-243
Parkinson's disease (PD) is a progressive neurodegenerative disorder with prominent motor and non-motor symptoms. Psychosis develops in over 40% of PD patients and it is one of the most distressing symptoms for patients and caregivers alike. Until re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d49a8b2312a2e71eb6a64eec5525959
https://doi.org/10.2174/1871527315666161006104347
https://doi.org/10.2174/1871527315666161006104347
Autor:
Anna, Petrovics-Balog, Zsófia, Majláth, Lukács, Melinda, Adrienn, Holczer, Anita, Must, János, Tajti, László, Vécsei
Publikováno v:
Ideggyogyaszati szemle. 72(11-12)
Migraine is one of the most disabling primary headache conditions. We aimed to detect hidden symptoms of anxiety and depression and to survey stress-coping mechanisms and related quality of life in a large migraine population without any known psychi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1a9cb5485893cd002757c10599820a86
https://pubmed.ncbi.nlm.nih.gov/31834683
https://pubmed.ncbi.nlm.nih.gov/31834683
Publikováno v:
Expert Opinion on Investigational Drugs. 25:1281-1294
The therapeutic management of Parkinson's disease (PD) is challenging and has not been fully resolved. The main challenges include motor fluctuations and levodopa-induced dyskinesia. Moreover, no disease-modifying or neuroprotective therapy is curren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8224a7cbaabbd2d2ce204c809b5b227
https://doi.org/10.1080/13543784.2016.1237501
https://doi.org/10.1080/13543784.2016.1237501
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 12:753-764
Painful diabetic neuropathy (PDN) is a disabling pain condition. Its pathomechanism remains unknown, but a sensitization and neuronal hyperexcitabilty have been suggested. Only symptomatic pharmacological pain management treatment is currently availa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1559eae58a6597b0f50962876729aa2
https://doi.org/10.1080/17425255.2016.1184648
https://doi.org/10.1080/17425255.2016.1184648
Publikováno v:
Expert Opinion on Biological Therapy. 16:787-799
The therapeutic management of Parkinson's disease has not yet been fully resolved, with motor fluctuations and levodopa-induced dyskinesia representing special therapeutic challenges. Furthermore, no disease-modifying therapies are currently availabl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77d9de0be7fbd3cb24c9502153d32b41
https://doi.org/10.1517/14712598.2016.1164687
https://doi.org/10.1517/14712598.2016.1164687
Autor:
Imre Dékány, G.K. Tóth, Ádám Juhász, Zsófia Majláth, Ferenc Bogár, Dániel Sebők, László Vécsei, J. Szolomájer, Edit Csapó
Publikováno v:
Colloids and Surfaces B: Biointerfaces. 133:66-72
In the course of our previous work, the interactions of two peptide fragments (GluR1201–230 and GluR1231–259) of human glutamate receptor (GluR1201–300) polypeptide with kynurenic acid (KYNA) were investigated by surface plasmon resonance (SPR)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bfed7d1b6c8c8912f35643227240dd1
https://doi.org/10.1016/j.colsurfb.2015.04.044
https://doi.org/10.1016/j.colsurfb.2015.04.044
Publikováno v:
Neuropeptides. 52:19-30
Migraine is a common disabling neurovascular primary headache disorder. The pathomechanism is not clear, but extensive preclinical and clinical studies are ongoing. The structural basis of the leading hypothesis is the trigeminovascular system, which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98eff5749a70bb5faa8c55b70a878051
https://doi.org/10.1016/j.npep.2015.03.006
https://doi.org/10.1016/j.npep.2015.03.006